Compass completes ISO Class 8 upgrade
US firm Compass Pharma Services is now offering ISO class 8 certified packaging services in a bid to capture a share of the expanding high-potency drug sector.
Preclinical services news in brief
In this week's review of activity within the preclinical research
services arena, news has emerged involving Genstruct, Morphosys,
Xencor and GVK Biosciences.
MDS Pharma opens large Phase I unit
MDS Pharma Services has opened its new Phase I clinic in Arizona -
the largest of its kind on the US west coast.
China gets serious on drug GMP; safety pact with FDA imminent
As of next year Chinese pharmaceutical manufacturers will face a
tougher time gaining good manufacturing practice (GMP)
certification after the country's regulator signalled new and
stricter standards were on the way.
Viracept contaminant could be widespread, FDA says
Following the recent news that pharma heavyweight Pfizer has also
been struck by contamination of its HIV drug Viracept (nelfinavir),
in-PharmaTechnologist.com spoke to the US Food and Drug
Administration (FDA) to find out how far...
The future of drug toxicity testing?
UK-based NanoBioDesign has received further investment to aid in
its commercialisation of a tool for testing drugs on P450 liver
enzymes, which could dramatically speed up drug toxicity testing.
Clinical trials funding affects results, says new research
Further evidence has emerged claiming that clinical trials are more
likely to report positive results when funded by drug companies.
Addex looks to prevent migraines
Addex Pharmaceuticals has announced its lead drug compound has
passed mid stage clinical trials, with the company aiming towards a
migraine prevention therapy.
'Embrace complexity' to enhance drug discovery
A Californian-based pharma firm has signalled that embracing the
complexity of human biology is the key to success in a wide range
of drug discovery processes.
Pharmatek opens new plant; Pace buys P3
Pharmatek has moved to a new larger lab and manufacturing facility
while Pace Analytical Life Sciences recently acquired lab testing
firm P3 Scientific.
Merck insomnia drug put to bed
A next-generation insomnia drug has been put to bed after its
developers decided the risk of using the drug outweighed its
potential benefit to millions of insomnia sufferers.
New software could curb drug failures
New software has been launched that its developers say will help
companies to spot drug candidate safety failures at an earlier
AtheroGenics rethink strategy for heart drug
A novel drug designed to prevent coronary heart disease has failed
a pivotal clinical trial although the developers are hopeful the
drug might still win approval.
MDS Pharma closes Quebec facility following FDA probe
MDS pharma has ceased operations at its bioanalytical services
facility in Blainville, Quebec in a bid to boost profitability
after an ongoing investigation of the site by the US Food and Drug
Aptuit continues service expansion
Aptuit has announced its intention to acquire SSCI, a leading solid
state chemistry company, just weeks after it bought the
pharmaceutical services division of technology firm EaglePicher.